T1	Participants 89 156	eradication of Helicobacter pylori in patients with duodenal ulcer.
T2	Participants 233 657	two parallel groups to assess the efficacy of ebrotidine (N-[(E)-[[2-[[[2-[(diaminomethylene) amino]-4-thiazolyl]methyl]thio]ethyl]amino] methylene]-4-bromo-benzenesulfonamide, CAS 100981-43-9, FI-3542) 400 mg and ranitidine 300 mg given in single evening dose, combined with amoxicillin 750 mg and metronidazole 500 mg three times daily for 14 days, in the eradication of Helicobacter pylori in patients with duodenal ulcer
T3	Participants 659 802	Thirty patients were included, divided into two groups of 15, to whom one of the study therapies was administered based on a randomization code
